Nine major PBMs agree to display TrumpRx drug prices on benefit tools

Key Points:

• Nine major pharmacy benefit managers (PBMs), including CVS Health and Humana, have agreed to integrate TrumpRx cash prescription prices into their benefit tools to enhance drug price transparency for patients.
• The initiative, supported by the Pharmaceutical Care Management Association (PCMA) and CMS Administrator Dr. Mehmet Oz, aims to help patients compare negotiated drug prices with TrumpRx cash prices to find the best deals and reduce costs.
• This transparency effort will apply to commercial, Medicare, and Medicaid plans and cover all drugs listed on TrumpRx, whether under presidential deals or standard pricing.
• PBMs will display TrumpRx pricing through Real Time Benefit Tools or other methods, enabling patients to make more informed decisions about prescription drug costs and access.
• The collaboration aligns with the Trump administration’s priority to lower prescription drug costs and has already helped Americans save over $700 million on medications via TrumpRx.